Medicrea entices US buyers with $36.4M in 2019 sales, an 11% increase YOY

Spine developer Medicrea posted 2019 sales of $36.4 million, representing an 11 percent increase year-over-year.

Advertisement

Five insights:

1. Fourth quarter revenue for 2019 was $9.4 million, the company’s best quarterly performance on a comparable basis.

2. Medicrea is currently pursuing one or more strategic partnerships.

3. More than 1,850 surgeries were performed with Medicrea implants in 2019, representing a 48 percent increase compared to 2018 and a 55 percent increase for the U.S. market alone.

4. Over 100 spine surgeons in the U.S. adapted the company’s UNiD Adaptive Spine Intelligence technology, with 50 surgeons implementing the system in 2019.

5. Medicrea reached 5,040 cumulative surgeries performed for 2019, surpassing its goal of 5,000.

More articles on devices:
4 spine, orthopedic surgeons jumping into politics in 2020
North Carolina spine practice, InteliChart partner to improve patient engagement
123-bed hospital acquires 1st spine robot in Bay Area — 3 things to know 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.